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Efficient Killing of Chronic B-Lymphocytic Leukemia Cells by Superantigen-Directed T Cells
By AnnaCarin Wallgren, Roger Festin, Cecilia Gidlof, Mikael Dohlsten, Terje Kalland, and Thomas H. Totterman
In vitro studies have indicated that chronic lymphocytic leukemia of B-cell origin (B-CLL) is resistant to cytotoxic effector lymphocytes such as natural killer and lymphokine activated killer (LAK) cells. We show here that B-CLL cells are sensitive to Staphylococcal enterotoxin (SE) A-directed T-cell killing. Activation of the target cells by phorbol ester (tetradecanoyl phorbol acetate, [TPA] ) greatly enhances their sensitivity to lysis. In SE-dependent cellular cytotoxicity (SDCC). members of the SE superantigen family form a bridge between T cells and target cells expressing major histocompatability complex class II molecules. Binding of SEA to the T-cell-receptor Vp region induces a strong cytotoxic capacity and cytokine production. Cells from 9 B-CLL patients were cultured in the presence or absence of TPA and used as targets in a 4-hour SDCC assay using an allogeneic T-cell line as effector. At an effector:target cell ratio 30:1, 70% to 80% of TPA-induced B-CLL cells were killed. Even at the effector:target ratio of 3:1, 47% 2 6%
of TPA-activated B-CLL cells were lysed compared with 13% 2 2% of resting cells (P < 
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nisms of SDCC lysis were investigated. Effector plus target cell supernatants contained high levels of tumor necrosis factor (TNF)-a and interferon-y, but these supernatants were not directly toxic to B-CLL cells in short term culture. High concentrations of recombinant TNF-a or TNF-8 had no lytic effect. Addition of neutralizing anti-TNF-a and anti-TNF-8 antibodies into the SDCC assay did not inhibit SEA-directed T-cell killing. TPA-activated B-CLL cells showed a 1.2-to 13-fold increased expression of the adhesion molecules intercellular adhesion molecule-I (ICAM-1 ), lymphocyte function-associated antigen (LFA)-1 , and LFA-3, whereas expression of HLA class I 1 molecules increased up to 5 times. The expression of CD72, CD40, and BB-lIB7 increased 1.8 to 4.5 times. The role of these surface molecules in SDCC was analyzed in blocking experiments with monoclonal antibodies. Antibodies to ICAM-1, CD18, and HLA-DR abolished the cytotoxicity, and a substantial reduction was seen with antibody to CD72. We conclude that superantigen-directed T cells deliver the most effective cell-mediated killing of B-CLL cells hitherto described. Lysis is dependent on direct cell-to-cell contact and involves CAM-1, CD18, and CD72 molecules. perantigens because of their ability to stimulate large numbers of human or murine T cells expressing particular Tcell-receptor (TCR) VP sequences.' Part of the SE molecule has high affinity for major histocompatability complex MHC class I1 molecules (particularly HLA-DR, but also -DQ and -DP) and is presented to the T cell as an unprocessed
The binding site is located outside the conventional peptide-binding groove." SEs interact with certain TCR-VP chain sequences and are the most potent T-cell activators known. CD4+ naive and memory cells and CD8+ cells respond by proliferation, production of cytokines such as interleukin-2 (IL-2), IFN-7, tumor necrosis factors (TNFs), and generation of strong cytotoxic capacity.''-13 SE-directed T cells kill not only HLA-DR+ tumor target cells but also normal DR+ cells such as activated T cells, B cells, and monocytes.14 Furthermore, it was shown that effector-target conjugate formation and lysis are dependent on cell adhesion molecule^.^^.^^ SE-directed T-cell killing was recently termed SE-dependent cell-mediated cytotoxicity (SDCC). l 3 Because of the reported high cytolytic efficiency of the SDCC mechanism, we investigated SEA-directed T-cell killing of primary B-CLL cells in vitro. Preactivated B-CLL cells were more efficiently lysed by SEA-specific T-cell lines than resting B-CLL cells. SDCC was far more efficient than lysis mediated by LAK cells and lectin-directed T cells. Activation of B-CLL cells and acquisition of sensitivity to lysis was paralleled by increased expression of several functionally important cell surface molecules.
MATERIALS AND METHODS

Reagents
SEA and SEB were obtained from Toxin Technology Inc (Madison, WI). Biotinylated SEA was prepared as previously described." use only.
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SUPERANTIGEN-MEDIATED KILLING OF B-CLL
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The following fluorescein (FITC)-or phycoerythrin (PE)-conjugated monoclonal antibodies (MoAbs; specificities in parentheses) and reagents were purchased from Becton Dickinson (Mountain View, CA) and used in two-color fluorescence-activated cell-sorter FACS analysis: anti-Leu-12-PE (CD 19), anti-Leu-2-PE (CD8), anti-Leu-3-FITC (CD4), Avidin-FITC, anti-Leu-1 0-FITC (HLA-DQ), and anti-HLA-DP. The MoAbs IOL58 (anti-lymphocyte function-associated antigen [LFAI-3), anti-CDS), IOL54 (anti-intercellular adhesion molecule-1 [anti-ICAM-11, anti-CD54), and IOT 16 (anti-LFA-1, antLCD1 la) were from Immunotech (Marseille, France). Tl l-1 (anti-CD2) and 9-49 (anti-HLA-DR) were kindly provided by Dr S. Schlossman (Dana-Farber Cancer Institute, Boston, MA). 1B4 (anti-CD18) was a gift from Dr. A. Gronberg (Kabi Pharmacia, Uppsala, Sweden), and BU40 (anti-CD72) and B-B20 (anti-CD40) were from Serotec (Oxford, UK). Anti-BB-l/B7 was kindly provided by Dr E. A. Clark (University of Washington, Seattle, WA). Anti-thyroid stimulating hormone (TSH) was a gift from Dr M. Carlsson (University ofuppsala, Uppsala, Sweden). Rabbit F(ab), anti-mouse Ig-FITC was obtained from Dakopatts (Glostrup, Denmark), and control mouse IgG was purchased from Coulter Immunology (Hialeah, Florida). Recombinant IL-2 and 51Cr were from Amersham (Buckingham Shire, UK). 12-0-tetradecanoyl phorbol 13-acetate (TPA) was obtained from Sigma (St. Louis, MO). Purified phytohemagglutinin (PHA) was from Wellcome Diagnostics (Dartford, UK). Immunoenzymetric assay kits (EASIA) for human TNF-a (sensitivity 3 pg/mL) and IFN-r (sensitivity 0.03 IU/mL) were purchased from Medgenix Diagnostics (Brussels, Belgium). Recombinant TNF-a and TNF-P were kindly provided by Dr G. Adolf (Ernst Boehringer Institute, Vienna, Austria). Rabbit anti-TNF-a and anti-TNF-fl antisera were generous gifts from Prof I. Olsson (University Hospital, Lund, Sweden). Each of these antisera diluted 1: 100 completely neutralized greater than 7,000 U/mL of rTNF-a and rTNF-0, respectively. Rabbit anti-SEA antibodies were kindly provided by Kabi-Pharmacia. RPMI 1640 (Flow Laboratories, Irvine, UK) supplemented with 10% fetal calf serum, 1 mmol/L nonessential amino acids, and 1 mmol/L pyruvate (GIBCO, Middlesex, UK) was used as complete medium.
Cell Lines
Human peripheral blood mononuclear cells (MNC) were isolated from a normal healthy subject by routine density centrifugation. An SEA-reactive T-cell line, SEA-T, was established by stimulation of these cells with SEA (1 ng/mL). The cell line was kept for weeks by repeated restimulation with SEA-coated irradiated (I3'Cs, 4,000 rad) BSM B-lymphoblastoid cellsls and rIL-2 (20 U/mL) in complete medium. It was then freeze-stored and thawed 1 to 2 weeks before use. The T-cell line was greater than 99% CD3+, greater than 98% CD8+, less than 2% CD4+ and responded by proliferation to SEA-coated BSM cells but not to uncoated or SEBcoated BSM cells. A T-cell line was similarly established from a B-CLL patient (no. 1). The patient T-cell line was greater than 99% CD3+, 47% CD8+, 42% CD4+. BSM and the LAK-cell-sensitive Daudi cell line were grown in log phase in complete medium.
Cell Cultures
Freeze-stored mononuclear cells from patients with untreated classic B-CLL (95% to 99% monoclonal CD19+ cells) were thawed, cultured for 3 days with or without TPA (1.6 X IO-' mol/L) in complete medium," and used as targets in the SDCC assay. Cells were also stained with MoAbs and phenotyped by FACS analysis (see below). MNC from a normal healthy subject were stimulated with 100 U/mL of rIL-2 for 3 days to obtain LAK cells. These LAK cells lysed 68'70, 48%, and 28% of Daudi cells at the corresponding effector:target ratios 30:1, lO:l, and 3:1, respectively. To study a possible cytotoxic "passive bystander effect" of SDCC supernatants on B-CLL targets, the effector SEA-T line was cocultured with targets from 2 patients (no. 1 and 3). The target cells were stimulated as above and preincubated with or without SEA (10 ng/mL). Two different effector:target cell ratios (30: 1 and 3: 1) were used. SEAcoated or uncoated effector or target cells cultured alone were used to produce control supernatants. The different supernatants were collected after 4 hours and 20 hours of culture and assayed for cytokines in EASIA. To analyze direct cytotoxicity, supernatants were added to different target cells in a 4-hour "Cr-release assay.
Cytotoxicity Assays SE-directed cytotoxicity. Cell-mediated cytotoxicity was measured at various effector:target cell ratios (30:1, lO:l, 3:1, 1:I) in a standard 4-hour "Cr-release assay and expressed as % specific lysis = 100 X (experimental cpm -background cpm/maximal cpmbackground cpm). Target cells were labeled for 2 hours with 51Cr (250 pCi/l X lo6 cells). Thereafter, the cells were preincubated with or without SE (10 ng/mL) for 30 minutes at room temperature, washed in complete medium, and seeded in v-bottomed microtitre plates at a concentration of 2.5 X lo3 cells/well. Indicated numbers of effector cells were added in 0.2 mL of complete medium. Supernatants were collected, and the released 51Cr was measured in a y counter (LKB-Wallac 1282, Uppsala, Sweden). Spontaneous release was estimated by incubation of target cells in medium alone, and maximum release by resuspending the wells with 0.1% Tween-20 (Sigma, St Louis, MO).
Cytotoxicity was measured as above at the same effector:target cell ratios and with 1 pg/mL PHA added directly into the assay. Lectin-mediated cytotoxicity was tested both in the absence and presence of SEA or SEB.
Supernatants from effector-and target-cell combinations cultured 4 hours or 20 hours (see above) were harvested and added to target cells from 2 patients (no. 1 and 3). Cytotoxicity was measured in the 4-hour 51Cr-release assay. The target cells were cultured *TPA as described and preincubated with or without SEA (10 ng/mL).
TNF-a-and TNF-@-mediated cytotoxicity. Target cells from 2 patients (no. 1 and 2) were incubated with rTNF-a (600,000, 60,000, and 6,000 U/mL) or rTNF-P (140,000, 14,000, and 1,400 U/mL). Chromium release was measured after 4 hours. The target cells were cultured +TPA and preincubated with or without SEA.
Blocking of TNF-a and TNF-P during SDCC. Rabbit anti-human TNF-a and anti-human TNF-P antibodies (diluted 1: 100) were added directly into the SDCC assay. At this dilution, each antiserum neutralized greater than 7,000 U/mL of TNF-(U and TNF-P in a bioassay using the TNF-sensitive cell line WEHI.I2 Normal rabbit serum and rabbit anti-SEA were used as negative and positive controls, respectively. TPA-activated and SEA-coated B-CLL cells from 2 patients (no. 1 and 2) were used as targets, and the SEA-T line as effector. Effectortarget ratios were 30: 1 and 3: 1.
Blocking of adhesion molecules in SEA-mediated cytotoxicity. In blocking experiments, different MoAbs were added at various concentrations directly into the assay. The effector:target ratio was 10: 1. Preincubation with SEA and/or the mere addition of MoAbs did not affect the spontaneous release of "Cr by the target cells (data not shown).
Blocking of HLA-DR on targets incubated with diflerent concentrations of SEA. In these experiments, the targets were preincubated with increasing concentrations of SEA (0.1, I, and 10 ng/ mL). Two different concentrations of MoAbs against HLA-DR were used to block the SDCC reaction at an E:T cell ratio of 10: 1.
Lectin-mediated cytotoxicity.
Cytotoxicity mediated by SDCC supernatants. 
RESULTS
Specificity ofthe Effector T-cell Line
To study the sensitivity of B-CLL cells to SE-directed Tcell killing, an SE-reactive T-cell line was established from a healthy donor by repeated stimulation with SEA-coated lymphoblastoid BSM cells. This T-cell line showed strong cytotoxicity against SEA-coated preactivated B-CLL cells but not against uncoated cells. The cytotoxicity against B-CLL cells preincubated with SEB was low, showing that the T-cell line was specific for SEA (Fig I) .
Lytic Eficacy of SEA-Directed T Cells Compared With Lectin-Directed T Cells and LAK Cells
Lectin-dependent killing of B-CLL cells. SEA-directed killing was also compared with lectin-mediated cytotoxicity. PHA was added directly into the assay with uncoated, SEA-coated, or SEB-coated target cells, respectively. As shown in Fig 1A and B, PHA mediated a similar but less effective cytotoxicity against both resting and TPA-activated CLL cells. The SEA-directed killing was not improved by the addition of PHA during the assay. Identical results were seen with tumor cells from 2 other patients. The impact of phorbol ester pretreatment of target cells is shown in Figs  2A and B. Two individual B-CLL clones were studied. Unstimulated cells from I patient (Fig 2A) were totally resistant, while 5 1% of the TPA-activated cells were lysed at a low E:T ratio of 3: 1. Resting cells from the second patient (Fig 2B) showed some sensitivity in SDCC, whereas the preactivated cells were lysed in a dose-response-dependent fashion (24% compared with 55% at an E:T ratio of 30:l). Thus, B-CLL cells had to be activated to be efficiently killed by SEA-directed T cells.
A T-cell line similarly established from B-CLL patient no. 1 lysed resting or TPA-activated autologous tumor cells as efficiently as the allogeneic effector cells (Fig 2C) .
B-CLL cells cultured with or without TPA are resistant to LAK cells. Normal blood mononuclear cells were cultured in the presence of 100 U rIL-2/mL for 3 days, and the cytotoxic capacity of the generated LAK cells was tested against B-CLL cells from several patients (Fig 3A) and against the standard LAK cell target Daudi. The latter cell type was highly sensitive (see Materials and Methods). To analyze whether activation could influence the sensitivity to LAK-mediated lysis, B-CLL cells were cultured for 3 days with or without TPA. At E:T ratio 10: 1. LAK cells were able Role of target cellpreactivation in SDCC. to kill 12% f 4% unstimulated and only 4% f 2% TPAstimulated B-CLL cells. Thus, TPA did not significantly alter the sensitivity of B-CLL cells to LAK-cell killing. Altogether, both resting and TPA-activated B-CLL cells were highly resistant to lysis by LAK cells.
Comparison of the eficacy of SEA-specific T cells and LAK cells to kill different targets. Figure 3 An SEA-T-cell line derived from B-CLL patient no. 1 was used against autologous tumor cells in (C). Cytotoxicity against uncoated or SEB-coated targets was close to 0% in each case (data not shown).
sitivity in SDCC. However, B-CLL cells activated with TPA were highly sensitive targets in SDCC. Even at a low E:T ratio of 3: 1, 47% +. 6% of TPA-activated B-CLL cells were lysed compared to 13% f 2% of unstimulated cells (Fig 3C) . LAK cells were fairly ineffective at killing uncoated targets (Fig 3A) but lysed some 30% to 40% of SEA-coated CLL targets at the highest E:T ratio, irrespective of whether targets were preactivated or not (Fig 3B) . 
As a control for nonspecific binding, rabbit antimouse F(ab),-FITC was used alone or in combination with irrelevant mouse lgG of the same isotype. No binding was seen with either of the latter combinations (data not shown).
TPA-Induced B-CLL Cells Show Increased Expression of Several Cell Surface Moleciiles and Binding of SEA
Phorbol-ester-induced phenotypic changes in CD 19+ B-CLL cells from 4 patients were studied by two-color FACS analysis using MoAbs to the MHC class I1 molecules HLA-DP, -DQ, -DR, and the adhesion molecules ICAM-I, LFA-3, LFA-I , and CD 18. The capacity of B-CLL cells to bind SEA was also measured. Furthermore, the expression of CD72, BB-I/B7, and CD40 was quantified in 2 patients (Fig  4) . Untreated B-CLL cells showed high levels of CD40 and MHC class I1 molecules but showed low levels of all adhesion molecules analyzed. After induction of the tumor cells with TPA, a 1.2-to 13-fold increase in expression of ICAM-I (relative fluorescence intensity for TPA-activated cells in arbitrary units [median and range], 182, 52 to 3 12), LFA-I ( 105,60 to 430) and LFA-3 ( 194, I 10 to 266) was registered (Fig 4) . Both the percentage of positive cells (data not shown) and mean cellular fluorescence intensity increased. The expression of MHC class I1 molecules and binding of SEA increased only slightly as to percent positive cells and up to 5 times with respect to fluorescence intensity (for HLA-DR median intensity 387, 98 to 630). B-CLL cell expression of CD72 (3 I , 46) , CD40 (247,423), and BB-I/B7 (20, 36) increased 1.5 to 4.5 times in 2 patients studied. An attempt was made to correlate the relative increase in expression of the studied cell surface antigens with sensitivity to lysis in SDCC. No such correlation was observed.
SEA-Directed Killing of B-CLL Cells is Blocked hv MoAhs t o HLA-DR. ICAM-I. CD18. and CD72
MoAbs against HLA-DR (ascites diluted 1:300 and 1500) were added to the SDCC assay using TPA-activated B-CLL target cells preincubated with increasing concentrations of SEA (0. I , I , and I O ng/mL). The cytotoxicity was completely abolished by both concentrations of MoAb, when targets coated with the lower concentrations of SEA were used. Using anti-HLA-DR MoAb diluted 1500 and targets preincubated with a high concentration of SEA ( I O ng/mL). 82% of the cytotoxicity was inhibited (Fig 5) . Further blocking experiments were performed with MoAbs to CD72, CD40 and the adhesion molecules ICAM-1, CDI 8, and LFA-3 to establish the significance ofthese molecules in SDCC against TPA-stimulated B-CLL cells (Fig 6) . A complete inhibition of SEA-mediated cytotoxicity was seen with 20 pg/mL of anti-ICAM-l MoAb in 1 of 2 patients tested (Fig 6A) . A similar dose-dependent decrease in percent cytotoxicity was observed with antLCD18 MoAb (Fig 6B) . Using MoAb against CD72, the cytotoxicity decreased from 62% to 1 1 % (Fig 6C) . Anti-LFA-3, anti-CD40, and anti-BB-1/B7 MoAbs did not interfere with SDCC against any ofthe target cell populations (Fig 6D) . In a control experiment with antLCD2 (TI 1-1 ascites 1:400) alone or in combination with anti-LFA-3, we observed no inhibition ofcytotoxicity by SEA-T against TPA-activated B-CLL cells (data not shown). An irrelevant control MoAb anti-TSH did not inhibit SDCC (Fig 6D) . Thus, the surface molecules ICAM-I/ LFA-I and CD72/CD5 play important roles in SEA-directed T-cell killing of B-CLL cells.
Cstokine Content and Cvtotoxic Effect of SDCC Assa.v Siipernatants
The production of TNF-a and IFN-y by the SEA-T cell line was measured by EASIA kits. The spontaneous release of TNF-a ranged from 14 to 18 pg/mL, and the release for IFN-y ranged from 0.8 to 1.1 IU/mL. In the presence of SEA or SEA-coated targets, the production of TNF-a and IFN-y increased 12.3 to 59 times and 4.6 to 7.5 times, respectively. We tested the "passive bystander" effect, ie cytotoxicity of these supernatants against TPA-stimulated B-CLL cells S E A in the absence of effector cells. No toxicity was observed as determined by the 4-hour chromium release assay (data not shown).
Efect of Addition or Blocking of TNF-a ana' TNF-@
High amounts of rTNF-a (600,000, 60,000, and 6,000 U/mL) or rTNF-@ (l40,000,14,000, and 1,400 U/mL) were added to resting or TPA-activated target cells (coated or not coated with SEA) from 2 patients (no. 1 and 2 ) in the absence of effector cells. No apparent cytotoxicity could be detected in any combination using the 4-hour chromium release assay (data not shown).
High local concentrations of TNF in the vicinity of the effector-target conjugate might be important in cytotoxicity. Therefore, neutralizing rabbit anti-TNF-a and anti-TNF-@ polyclonal antibodies (final dilutions I : 100) were added simultaneously into SDCC assays containing SEA-T effector cells and TPA-activated SEA-coated target cells from 2 patients (no. 1 and 2). No inhibition of chromium release was observed (Fig 7) . Normal rabbit serum did not interfere with SDCC, but, as expected, rabbit anti-SEA had a blocking effect on the ability of effectors to mediate cytotoxicity. The present results show that SEA-directed T cells kill preactivated B-CLL tumor cells more efficiently than lectindirected T cells, whereas LAK cells are virtually ineffective in this regard. This emphasizes the similarity between SEAand lectin-mediated killing, both of which use a T-cell-activating ''linker'' molecule between the effector and target cell. Further evidence for the need of direct cell-to-cell contact in SDCC comes from our studies with culture supernatants. The SEA-directed effector T-cell lines produced considerable amounts of both TNF-a and IFN-y when cocultured with SEA-coated B-CLL cells. However, such supernatants were not toxic to B-CLL targets in the 4-hour chromium release assay. Furthermore, addition ofvery high concentrations of rTNF-a and rTNF-fl did not mediate cytotoxicity, and neutralization of spontaneous TNF with antibody did not inhibit SDCC. Taken together, these observations speak against an important role for TNF as a mediator of lysis in SDCC of B-CLL. Preliminary observations indicate that effector T-cell lines express high levels of mRNA for perforin, a molecule mediating direct T-/NK-cell killing of targets.
In cytotoxic T-cell-and NK-/LAK-cell-mediated killing, complementary adhesion molecules on the effector and target cells, respectively, have been shown to enhance conjugate strength and improve lytic efficiency. These adhesion molecules include ICAM-I/LFA-1, LFA-3/CD2, and CD28/BB-1 .31-34 Therefore, we compared the density of adhesion and MHC class I1 molecules on resting and TPAstimulated B-CLL cells to study whether differences in their expression could account for changes in target cell sensitivity. Phorbol-ester activation was accompanied by a 1.2-to 13-fold increase in fluorescence intensity for ICAM-1, LFA-1, and LFA-3 and by a slight increase in expression of class I1 molecules. The latter was paralleled by an increased binding of SEA. To evaluate the role of surface molecules in SDCC, several experiments were performed using blocking MoAbs. Antibody to HLA-DR inhibited lysis most probably by abrogating the ligation of effector T-cells to the SEAtarget cell complex. The expression and engagement of the BB-l/B7 and CD40 surface antigens in SEA-/T-cell-mediated lysis of B-CLL cells was investigated. BB-1 is a B-cell-specific activation antigen,38 and its natural ligand was recently shown to be CD28, a cytokine regulating T-cell molecule. 34 The expression of BB-I/B7 on B-CLL cells increased after TPA induction, but blocking experiments with anti-BB-1 indicated that this molecule is not involved in SDCC of B-CLL cells. However, we did not have the opportunity to study the effects of MoAb to CD28. CD40 is a type I integral pan-Bcell membrane protein, and ligation of the molecule with antibody induces homotypic adhesion, proliferation, and differentiati~n.~~ B-B-cell aggregation mediated through CD40 is secondary to induction of the ICAM-I /LFA-1 syst em: '
The murine natural ligand (CD40L) for CD40 was recently shown on the surface of activated T cells.41 TPA-induced B-CLL cells had increased surface expression of CD40. However, blocking antibodies to the molecule had no apparent effect on SDCC.
The involvement of the pan-B-cell surface molecule CD72 in SEA-dependent T-cell-mediated lysis of B-CLL cells was investigated. Preactivation of B-CLL cells with phorbol ester increased their sensitivity to lysis and increased the surface expression of CD72 as well. Furthermore, antibody to CD72 almost completely blocked lysis of B-CLL cells, indicating the importance of this molecule in SDCC. CD72 is a pan-B cell Ca2+-dependent type I1 integral protein with homology to CD23. Antibody ligation of CD72 promotes entry to cell cycle, upregulates HLA class 11, and enhances T-cell-dependent d i f f e r e n t i a t i~n .~~.~~ The natural ligand for CD72 is CD5, a molecule present on T 
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Although the present results clearly show an important role for ICAM-I, CD18, and CD72 molecules in SEA-directed T-cell-mediated lysis of B-CLL, we were unable to show a positive correlation between cellular expression and sensitivity to lysis. Thus, other surface molecules may be pivotal. In the mouse, cytotoxic T-cell-mediated programmed cell death, or apoptosis, involves the ligation of the apoptosis-inducing Fas molecule on the target cells. 46 The human equivalent molecule APO-1 was recently cloned and included the TNF/NGF receptor ~uperfamily.~' Studies ofthe APO-I molecule should be considered in clarifying the cytotoxic mechanisms of SDCC.
Adhesion molecules on various cell types are susceptible to modulations by several physiologic fact0rs,4&'~ and Rousset et a15 ' showed that IL-4 may induce expression of certain adhesion molecules on B-cell lines. It is not excluded that SEA-/T-cell-mediated killing could be useful in purging of B-CLL cells in vitro, because preliminary results have shown that IL-4, IFN-7, and TNF-a also modulate adhesion molecules on B-CLL cells (data not shown). However, it would be desirable to use B-cell-specific target structures instead of MHC class I1 molecules, because the latter are widely distributed among many normal cell types. Dohlsten et alsZ showed that the target-cell specificity of SEA can be redirected by conjugating the molecule to suitable MoAbs with retained T-cell-activating properties. Recently, recombinant fusion proteins between SEA and MoAbs were constructed that had a significantly reduced binding to MHC class I1 antigens facilitating in vivo appli~ation.~~ B-CLL might be an interesting target for the exploration of the clinical usefulness of similar hybrid molecules based on MoAbs to pan-B-cell surface structures such as CD19 or CD20.
